Study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer

11:27 EDT 25 Mar 2019 | ecancermedicalscience

White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint blockade (ICB) therapy. The results from this study will be presented at the AACR Annual Meeting 2019 in...

More From BioPortfolio on "Study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer"